US Stock MarketDetailed Quotes

OVID Ovid Therapeutics

Watchlist

1.050
-0.010-0.94%

Close Nov 22 16:00 ET

1.040
-0.010-0.95%

Post 20:01 ET

74.56MMarket Cap-2282P/E (TTM)

Ovid Therapeutics Stock Forum

MARKET-TEST-DUMMY

Jul 20 09:27

👀

$Ovid Therapeutics (OVID.US)$

70205719

Jul 12 16:19

$Ovid Therapeutics (OVID.US)$ break 1.17 next week, then fill in the gap sooner.

TraderKen26

Jul 1 19:11

$Ovid Therapeutics (OVID.US)$ why the super dump?

Jaguar8

Jul 1 13:07

NEWS

$Ovid Therapeutics (OVID.US)$
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
Ovid Therapeutics and Graviton Bioscience announced positive Phase 1 trial results for their OV888/GV101 capsule, a potential first-in-class therapy for cerebral cavernous malformations (CCM). The trial met its primary objective by demonstrating a favorable safety and to...

Jaguar8

Jun 17 06:40

NEWS

$Ovid Therapeutics (OVID.US)$
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
Ovid Therapeutics reported on Takeda's Phase 3 study results for soticlestat, a treatment for Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS). The Skyline study in DS narrowly missed its primary endpoint but showed significant effects in secondary endpoints with p-values ≤ 0.008. The Skyway study in LGS missed its primary endpoint. Soticlestat had a favorabl...

Moomoo AI

Oct 18, 2023 07:50

Soticlestat's potential in treating Lennox-Gastaut and Dravet syndromes is backed by Ovid and Ligand's deal. Ligand sees the deal aligning with its strategy of investing in solutions answering high unmet needs, promising high-margin growth for its investors.

Press Release: Ovid Therapeutics and Ligand Pharmaceuticals Enter Into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway Into 2026

Weight-loss drugmakers report strong earnings: Boon or bane?

JayGonzo

Mar 3, 2021 17:24

$Castor Maritime (CTRM.US)$
Positions Details
I hope everyone had a good day on the markets. When the stock drops and you get that urge to sell. HOLD we can’t stop these short sellers from manipulation unless we stay bullish and stop selling out of fear. When they dip buy more.
I have bags of $Ovid Therapeutics (OVID.US)$ I have bags and contracts with $SOS Ltd (SOS.US)$ up a total today of 1130% $Castor Maritime (CTRM.US)$ is great see major potential in the future. $Super League Gaming (SLGG.US)$